TRIM31 and acute myeloid leukemia: Similarly, Xu et al. recently reported that TRIM31 boosted cancer progression and sensitivity to daunorubicin in acute myeloid leukemia by regulating Wnt/β-catenin signaling19; however, the exact regulatory mechanism involved remains unclear.